Japan Cracks Down on Misuse of Trial Data; Pfizer Confirms It Faces Probe

International Pharmaceutical Regulatory Monitor
A A
Japanese officials launched an investigation Jan. 10 into claims that falsified clinical trial data were used in an Alzheimer’s study involving several major drugmakers, marking an expansion of the country’s scrutiny of trial data misuse.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00